Malformations of Cortical Development, Group I
"Malformations of Cortical Development, Group I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cortical malformations secondary to abnormal neuronal and glial CELL PROLIFERATION or APOPTOSIS in NEUROGENESIS. This group includes congenital MICROCEPHALIES; MICROLISSENCEPHALIES, megalencephalies, HEMIMEGALENCEPHALIES and cortical dysplasias with balloon cells.
Descriptor ID |
D065703
|
MeSH Number(s) |
C10.500.507.400 C16.131.666.507.400
|
Concept/Terms |
Malformations of Cortical Development, Group I- Malformations of Cortical Development, Group I
- Malformations Due to Abnormal Neuronal and Glial Proliferation or Apoptosis
- Malformations Secondary to Abnormal Neuronal and Glial Proliferation or Apoptosis
- Abnormal Proliferation Cortical Malformations
- Cortical Malformations, Group I
|
Below are MeSH descriptors whose meaning is more general than "Malformations of Cortical Development, Group I".
Below are MeSH descriptors whose meaning is more specific than "Malformations of Cortical Development, Group I".
This graph shows the total number of publications written about "Malformations of Cortical Development, Group I" by people in this website by year, and whether "Malformations of Cortical Development, Group I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Malformations of Cortical Development, Group I" by people in Profiles.
-
Magnetoencephalography and New Imaging Modalities in Epilepsy. Neurotherapeutics. 2017 01; 14(1):4-10.
-
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol. 2017 02; 23(1):141-146.